Envista Holdings Co. (NYSE:NVST) SVP Mischa Reis sold 25,479 shares of the business’s stock in a transaction that occurred on Friday, May 7th. The shares were sold at an average price of $45.88, for a total value of $1,168,976.52.
Mischa Reis also recently made the following trade(s):
- On Monday, May 3rd, Mischa Reis sold 1,049 shares of Envista stock. The stock was sold at an average price of $43.73, for a total value of $45,872.77.
Shares of Envista stock opened at $42.84 on Wednesday. Envista Holdings Co. has a 52 week low of $20.22 and a 52 week high of $46.52. The company has a fifty day simple moving average of $43.66. The firm has a market cap of $6.89 billion, a price-to-earnings ratio of 63.00, a PEG ratio of 0.87 and a beta of 1.93. The company has a current ratio of 1.02, a quick ratio of 0.77 and a debt-to-equity ratio of 0.24.
Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, May 5th. The company reported $0.54 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.31 by $0.23. Envista had a return on equity of 6.93% and a net margin of 5.00%. The business had revenue of $709.20 million for the quarter, compared to analyst estimates of $636.89 million. On average, research analysts expect that Envista Holdings Co. will post 1.89 earnings per share for the current year.
Several institutional investors have recently made changes to their positions in the company. Prudential Financial Inc. lifted its stake in Envista by 542.8% during the 1st quarter. Prudential Financial Inc. now owns 46,922 shares of the company’s stock worth $1,914,000 after acquiring an additional 39,622 shares in the last quarter. BlackRock Inc. lifted its stake in Envista by 2.0% during the 1st quarter. BlackRock Inc. now owns 11,969,160 shares of the company’s stock worth $488,342,000 after acquiring an additional 231,443 shares in the last quarter. Pura Vida Investments LLC lifted its stake in Envista by 53.1% during the 1st quarter. Pura Vida Investments LLC now owns 283,176 shares of the company’s stock worth $11,554,000 after acquiring an additional 98,176 shares in the last quarter. Public Employees Retirement System of Ohio lifted its stake in Envista by 8.1% during the 1st quarter. Public Employees Retirement System of Ohio now owns 84,745 shares of the company’s stock worth $3,458,000 after acquiring an additional 6,341 shares in the last quarter. Finally, Norges Bank acquired a new position in Envista during the 4th quarter worth about $67,374,000.
Several analysts recently commented on NVST shares. Piper Sandler boosted their price target on Envista from $41.00 to $45.00 and gave the stock a “neutral” rating in a research report on Thursday, May 6th. Zacks Investment Research upgraded Envista from a “hold” rating to a “strong-buy” rating and set a $52.00 price target for the company in a research report on Saturday, May 8th. Credit Suisse Group boosted their price target on Envista from $49.00 to $55.00 and gave the stock an “outperform” rating in a research report on Thursday, May 6th. TheStreet upgraded Envista from a “d+” rating to a “c” rating in a research report on Thursday, May 13th. Finally, Morgan Stanley boosted their price target on Envista from $42.00 to $46.00 and gave the stock an “equal weight” rating in a research report on Friday, May 7th. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $43.33.
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company’s Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands.
Read More: What is a Lock-Up Period?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured Article: What does a bar chart mean for investors?
One of the lingering impacts of the Covid-19 pandemic is the supply chain disruptions that continue to bedevil many sectors. By now, every investor is aware of the global chip shortage that is disrupting many sectors that were projected to have strong growth in 2021.
But there are many more sectors that are being affected by supply chain disruptions. And this affects everything from big-ticket items like cars to everyday items like pet food and even bacon.
The focus of this special presentation is seven companies that stand to benefit from the current disruption in the supply chain. All of these companies delivered strong gains in 2020. Some of them have weakened in 2021, but that was before the full extent of the supply chain weakness was discovered.
As the economy reopens, the shortage of items is likely to continue and become much more notable. When they do, many of these stocks may get overpriced. That’s why now is the time to get in on these stocks that can help you work the supply chain in your favor.